Expert Details
Cardiovascular Drugs & Therapy, Hypertension Development, Blood Flow, etc.
ID: 716679
Texas, USA
Expert has been studying the mechanisms responsible for causing certain types of acute renal failure, particularly hypovolemic shock, free radical-induced injury, and endotoxin shock. The major aim is to determine whether dopamine and/or selective dopamine receptor agonists will be effective in improving renal blood flow and function in these types of acute renal failure. Some of his studies indicate that these drugs are indeed effective in improving renal function, as well as survival in models of acute renal failure.
Dopamine, although a neurotransmitter in the brain, also serves as an important role in the periphery in controlling kidney functions by regulating renal sodium excretion. Expert's research in this area has identified receptors in the kidney where dopamine acts to increase blood flow and sodium excretion. This research has also led to the postulation that a defect in the ability of dopamine to promote sodium excretion may give rise to hypertension of renal origin. The cellular signaling mechanisms that may be responsible for such a biochemical defect are currently under investigation.
Expert's research in this area is aimed at determining local (biochemical and physical) humoral and nervous factors that influence blood flow to vital organs. Also, studies are conducted to determine how changes in sympathetic and neuroeffector function would modify blood flow, and the mechanism by which drug affects blood flow to selective organs, which may eventually lead to a better understanding of drug action.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1975 | Degree: Ph.D. | Subject: Pharmacology | Institution: University of Houston |
| Year: 1968 | Degree: M.S. | Subject: Pharmacology | Institution: Columbia University |
| Year: 1966 | Degree: B.S. | Subject: Pharmacy | Institution: Gujarat University - India |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 1991 to 2002 | Employer: University of Houston | Title: Dean and Professor | Department: College of Pharmacy |
Responsibilities:Available upon request. |
|||
| Years | Employer | Title | Department |
| Years: 1989 to 1991 | Employer: University of Houston | Title: Professor and Chairman | Department: College of Pharmacy |
Responsibilities:Available upon request. |
|||
| Years | Employer | Title | Department |
| Years: 1988 to 1989 | Employer: University of Houston | Title: Associate Professor and Chairman | Department: College of Pharmacy |
Responsibilities:Available upon request. |
|||
| Years | Employer | Title | Department |
| Years: 1975 to 1980 | Employer: University of Houston | Title: Assistant Professor | Department: College of Pharmacy |
Responsibilities:Available upon request. |
|||
Career Accomplishments
| Associations / Societies |
|---|
| Expert is a member of 16 scientific and professional societies and serves on several committees of various associations. |
| Awards / Recognition |
|---|
| Expert received the Research Excellence Award from Sigma Xi, the scientific research society. He is a Fellow of the Council for High Blood Pressure Research of the American Heart Association. |
| Publications and Patents Summary |
|---|
| He is Associate Editor of five books, co-editor of two journal supplements, has written 23 book chapters, 19 review articles, and 120 research papers in scientific journals. |
Fields of Expertise
arterial hypertension, antihypertensive drug, hypertension, cardiovascular disease, cardiovascular system, cardiovascular drug therapy, dopamine, blood flow, hemorheology, cardiovascular abnormality, nephrology research, creatinine, acute renal failure, excretion process, agonistic drug, blood flow measurement, blood pressure, cold pharmacology, biological aging, nephrology, renal hypertension, physiology, pharmacology, over-the-counter drug, oral contraceptive drug, investigational drug, injectable drug, hypovolemic shock, heart disease, heart, gastrointestinal drug, drug therapy, congestive heart failure, animal model